rs41273519
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_003126.4(SPTA1):c.6421C>T(p.Arg2141Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0027 in 1,613,944 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2141Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_003126.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTA1 | NM_003126.4 | c.6421C>T | p.Arg2141Trp | missense_variant | 45/52 | ENST00000643759.2 | NP_003117.2 | |
SPTA1 | XM_011509916.3 | c.6421C>T | p.Arg2141Trp | missense_variant | 46/53 | XP_011508218.1 | ||
SPTA1 | XM_011509917.4 | c.6421C>T | p.Arg2141Trp | missense_variant | 45/51 | XP_011508219.1 | ||
SPTA1 | XM_047428883.1 | c.6100C>T | p.Arg2034Trp | missense_variant | 45/52 | XP_047284839.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTA1 | ENST00000643759.2 | c.6421C>T | p.Arg2141Trp | missense_variant | 45/52 | NM_003126.4 | ENSP00000495214.1 | |||
SPTA1 | ENST00000484520.1 | n.624C>T | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00256 AC: 390AN: 152082Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00200 AC: 500AN: 249544Hom.: 2 AF XY: 0.00183 AC XY: 248AN XY: 135384
GnomAD4 exome AF: 0.00271 AC: 3964AN: 1461744Hom.: 7 Cov.: 31 AF XY: 0.00258 AC XY: 1879AN XY: 727178
GnomAD4 genome AF: 0.00256 AC: 390AN: 152200Hom.: 1 Cov.: 32 AF XY: 0.00253 AC XY: 188AN XY: 74406
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 06, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 06, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | SPTA1: BS1, BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 07, 2023 | - - |
Elliptocytosis 2 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | May 04, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | Jan 31, 2023 | - - |
Hereditary spherocytosis type 3 Pathogenic:1Uncertain:1
Likely pathogenic, flagged submission | clinical testing | Department of Genetic, Henri Mondor Hospital, Assistance Publique des Hôpitaux de Paris | Feb 27, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Pyropoikilocytosis, hereditary Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at